Europe Weight Loss Supplements Market Size & Outlook, 2025-2033

Europe Weight Loss Supplements Market Insights

As highlighted in Deep Market Insights analysis, the Europe Weight Loss Supplements Market, valued at USD 11978.56 Million in 2024, is estimated to achieve USD 39274.72 Million by 2033.
The market is estimated to grow at a CAGR of 14.04% spanning 2026 to 2033.
By market size, Pills / capsules led the Product Form category in 2024.
The Product Form segment led by Pills / capsules is estimated to post the fastest growth, sustaining its position as the most lucrative during the forecast timeframe.

The global Weight Loss Supplements Market size saw Europe holding a share of 36.52% in 2024.
United States is forecasted to account for the leading share of the global market by 2033.
In Europe, Russia is forecasted to be the fastest-expanding market, projected to reach USD 3659.5 Million by 2033.

Report Scope	Details
Base Year for Study	2024
Study Period	2021-2033
Historical Period	2021-2023
Forecast Period	2025-2033
Market Size In 2024	USD 11978.56 Million
Market Size In 2033	USD 39274.72 Million
Largest segment	Pills / capsules
Units	Revenue in USD Million
CAGR	14.04% (2025-2033)
Segmnetation Covered
Europe	Germany United Kingdom France Italy Spain Russia Nordic Benelux
Product Form	Pills / capsules Powders Drinks / ready-to-drink
Ingredient Type	Herbal / botanical Protein / meal replacements Thermogenic / stimulant-based
Distribution Channel	Pharmacies Online retail Health / nutrition stores
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Europe	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Germany	XX.x	XX.x	XX.x	2994.64	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
United Kingdom	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
France	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Italy	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Spain	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Russia	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Nordic	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Benelux	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: DMI Analysis Company Publications, Primary Interviews.

Product Form	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Pills / capsules	XX.x	XX.x	XX.x	5923.4	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Powders	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Drinks / ready-to-drink	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: DMI Analysis Company Publications, Primary Interviews.

Ingredient Type	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Herbal / botanical	XX.x	XX.x	XX.x	5633.52	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Protein / meal replacements	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Thermogenic / stimulant-based	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: DMI Analysis Company Publications, Primary Interviews.

Distribution Channel	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Pharmacies	XX.x	XX.x	XX.x	5426.29	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Online retail	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Health / nutrition stores	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x